Smith Could a simple blood test predict your risk of getting dementia years, or even decades, before you experience memory ...

New research published in The Journal of Clinical Investigation argues that Alzheimer’s may begin much earlier than ...

New analyses show DLB patients with lower plasma pTau181 levels - indicating an earlier stage of disease and absence of ...

A simple test could detect Alzheimer's years before symptoms appear, offering hope for earlier intervention and treatment.

The study analyzed the evolution of white matter hyperintensities (WMH), lesions typically associated with cerebral vascular ...

What has long been interpreted as permanent and irreversible vascular damage may not be exclusively so. In people with Down syndrome—one of the most robust populations for studying Alzheimer's disease ...

Donanemab and lecanemab have been shown to delay progression from mild to moderate Alzheimer's by up to six months but are ...

NHS watchdog to review evidence on two pioneering Alzheimer’s drugs - Donanemab and lecanemab were licensed for use in the UK in 2024 but were not made available on the NHS after Nice deemed their ben ...

Annovis Bio, Inc. (NYSE: ANVS) ('Annovis” or the 'Company”), a Phase 3 clinical-stage biotechnology company developing the ...

The NHS spending watchdog must look again at its decision after drug manufacturers successfully appealed against Nice's ruling that the treatments were not cost-effective ...

Hormonal changes during menopause can significantly increase Alzheimer's disease (AD) risk in women due to a drop in estrogen ...

Alzheimer’s disease affects millions of people around the world and is one of the leading causes of memory loss and cognitive ...